Schroder Investment Management Group raised its position in shares of Itron, Inc. (NASDAQ:ITRI - Free Report) by 42.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 253,526 shares of the scientific and technical instruments company's stock after purchasing an additional 75,166 shares during the quarter. Schroder Investment Management Group owned 0.56% of Itron worth $27,528,000 at the end of the most recent quarter.
A number of other hedge funds also recently modified their holdings of the business. Cerity Partners LLC acquired a new stake in shares of Itron during the third quarter worth approximately $454,000. The Manufacturers Life Insurance Company lifted its position in Itron by 2.2% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 26,231 shares of the scientific and technical instruments company's stock worth $2,802,000 after buying an additional 571 shares in the last quarter. Glenmede Trust Co. NA boosted its stake in shares of Itron by 2.2% during the 3rd quarter. Glenmede Trust Co. NA now owns 6,220 shares of the scientific and technical instruments company's stock valued at $664,000 after buying an additional 134 shares during the period. Captrust Financial Advisors purchased a new position in shares of Itron during the 3rd quarter valued at $215,000. Finally, Point72 Asia Singapore Pte. Ltd. increased its stake in shares of Itron by 23.7% in the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 2,305 shares of the scientific and technical instruments company's stock worth $246,000 after acquiring an additional 442 shares during the last quarter. Hedge funds and other institutional investors own 96.19% of the company's stock.
Analysts Set New Price Targets
A number of analysts recently issued reports on ITRI shares. Piper Sandler lifted their price objective on Itron from $119.00 to $124.00 and gave the company a "neutral" rating in a research report on Thursday, February 27th. Oppenheimer lifted their price target on Itron from $124.00 to $131.00 and gave the company an "outperform" rating in a report on Wednesday, February 26th. Canaccord Genuity Group boosted their price target on Itron from $130.00 to $132.00 and gave the company a "buy" rating in a research note on Wednesday, February 26th. Guggenheim cut their price objective on shares of Itron from $135.00 to $133.00 and set a "buy" rating on the stock in a research report on Thursday, February 27th. Finally, StockNews.com downgraded shares of Itron from a "strong-buy" rating to a "buy" rating in a research report on Saturday, March 1st. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $127.64.
Get Our Latest Research Report on Itron
Itron Stock Performance
NASDAQ:ITRI traded down $0.41 during midday trading on Monday, reaching $94.38. The stock had a trading volume of 890,083 shares, compared to its average volume of 560,119. The stock has a market capitalization of $4.30 billion, a P/E ratio of 19.34, a PEG ratio of 0.81 and a beta of 1.39. Itron, Inc. has a 1-year low of $88.87 and a 1-year high of $124.90. The company has a debt-to-equity ratio of 0.91, a current ratio of 3.36 and a quick ratio of 2.83. The firm's fifty day simple moving average is $103.59 and its 200-day simple moving average is $107.94.
Insider Activity
In related news, CAO David Marshall Wright sold 317 shares of the company's stock in a transaction on Monday, February 24th. The shares were sold at an average price of $92.90, for a total transaction of $29,449.30. Following the completion of the transaction, the chief accounting officer now directly owns 8,108 shares in the company, valued at $753,233.20. This represents a 3.76 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Christopher E. Ware sold 648 shares of the stock in a transaction on Monday, February 24th. The shares were sold at an average price of $92.90, for a total transaction of $60,199.20. Following the completion of the sale, the senior vice president now directly owns 20,326 shares of the company's stock, valued at approximately $1,888,285.40. This trade represents a 3.09 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 4,037 shares of company stock valued at $385,815. 1.45% of the stock is owned by insiders.
About Itron
(
Free Report)
Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.
See Also

Before you consider Itron, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.
While Itron currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.